Diabetes Care 28:385-390, 2005
© 2005 by the American Diabetes Association, Inc.
Metabolic Syndrome/Insulin Resistance Syndrome/Pre-Diabetes Original Article |
The Metabolic Syndrome and 11-Year Risk of Incident Cardiovascular Disease in the Atherosclerosis Risk in Communities Study
Ann Marie McNeill, PHD1,
Wayne D. Rosamond, PHD1,
Cynthia J. Girman, DRPH2,
Sherita Hill Golden, MD, MHS3,
Maria I. Schmidt, MD4,
Honey E. East, MD5,
Christie M. Ballantyne, MD6 and
Gerardo Heiss, MD, PHD1
1 Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
2 Department of Epidemiology, Merck Research Laboratories, Rahway, New Jersey
3 Department of Medicine, Johns Hopkins University School of Medicine and Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland
4 Graduate Studies Program in Epidemiology, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
5 Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi
6 Methodist DeBakey Heart Center and Department of Medicine, Baylor College of Medicine, Houston, Texas
Address correspondence and reprint requests to Dr. Wayne Rosamond, University of North Carolina, Chapel Hill, 137 E. Franklin St, Chapel Hill, NC 28514. E-mail: wayne_rosamond{at}unc.edu
OBJECTIVE To assess the magnitude of the association between the National Cholesterol Education Programs Third Adult Treatment Panel Report (ATP III) definition of the metabolic syndrome and cardiovascular disease (CVD).
RESEARCH DESIGN AND METHODS Cox regression was used to estimate the relative risk of incident coronary heart disease (CHD) and stroke among 12,089 black and white middle-aged individuals in the Atherosclerosis Risk in Communities (ARIC) study.
RESULTS The metabolic syndrome was present in 23% of individuals without diabetes or prevalent CVD at baseline. Over an average of 11 years of follow-up, 879 incident CHD and 216 ischemic stroke events occurred. Among the components of the metabolic syndrome, elevated blood pressure and low levels of HDL cholesterol exhibited the strongest associations with CHD. Men and women with the metabolic syndrome were 1.5 and 2 times more likely to develop CHD than control subjects after adjustment for age, smoking, LDL cholesterol, and race/ARIC center (sex interaction P < 0.03). Similar associations were found between the metabolic syndrome and incident ischemic stroke. Comparison of receiver operating characteristic curves indicated that the metabolic syndrome did not materially improve CHD risk prediction beyond the level achieved by the Framingham Risk Score (FRS).
CONCLUSIONS Individuals without diabetes or CVD, but with the metabolic syndrome, were at increased risk for long-term cardiovascular outcomes, although statistical models suggested that most of that risk was accounted for by the FRS. Nevertheless, identification of individuals with the metabolic syndrome may provide opportunities to intervene earlier in the development of shared disease pathways that predispose individuals to both CVD and diabetes.
Abbreviations: ARIC, Atherosclerosis Risk in Communities ATP III, Third Adult Treatment Panel Report CHD, coronary heart disease CVD, cardiovascular disease FRS, Framingham Risk Score ROC, receiver operating characteristic

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. F. Arenillas, L. Ispierto, M. Millan, D. Escudero, N. Perez de la Ossa, L. Dorado, C. Guerrero, J. Serena, J. Castillo, and A. Davalos
Metabolic syndrome and resistance to IV thrombolysis in middle cerebral artery ischemic stroke
Neurology,
July 15, 2008;
71(3):
190 - 195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Taylor, J. Liu, G. Wilson, S. H. Golden, E. Crook, C. D. Brunson, M. Steffes, W. D. Johnson, and J. H. Sung
Distinct Component Profiles and High Risk Among African Americans With Metabolic Syndrome: The Jackson Heart Study
Diabetes Care,
June 1, 2008;
31(6):
1248 - 1253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Mozaffarian, A. Kamineni, R. J. Prineas, and D. S. Siscovick
Metabolic Syndrome and Mortality in Older Adults: The Cardiovascular Health Study
Arch Intern Med,
May 12, 2008;
168(9):
969 - 978.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wang, S. Ruotsalainen, L. Moilanen, P. Lepisto, M. Laakso, and J. Kuusisto
The Metabolic Syndrome Predicts Incident Stroke: A 14-Year Follow-Up Study in Elderly People in Finland
Stroke,
April 1, 2008;
39(4):
1078 - 1083.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Tabara, H. Osawa, R. Kawamoto, R. Tachibana-Iimori, M. Yamamoto, J. Nakura, T. Miki, H. Makino, and K. Kohara
Reduced High-Molecular-Weight Adiponectin and Elevated High-Sensitivity C-Reactive Protein Are Synergistic Risk Factors for Metabolic Syndrome in a Large-Scale Middle-Aged to Elderly Population: the Shimanami Health Promoting Program Study
J. Clin. Endocrinol. Metab.,
March 1, 2008;
93(3):
715 - 722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Needs Assessment
The Diabetes Educator,
March 1, 2008;
34(Supplement_2):
30S - 31S.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. B. Haas
The Role of the Diabetes Educator: Patient Case Scenarios
The Diabetes Educator,
March 1, 2008;
34(Supplement_2):
32S - 36S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Hollander
Cardiometabolic Risk Factors and Visceral Adipose Tissue
The Diabetes Educator,
March 1, 2008;
34(Supplement_2):
37S - 41S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. L. Lutsey, L. M. Steffen, and J. Stevens
Dietary Intake and the Development of the Metabolic Syndrome: The Atherosclerosis Risk in Communities Study
Circulation,
February 12, 2008;
117(6):
754 - 761.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S. M. Hailpern, M. Ho, V. Howard, B. Kissela, et al.
Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Circulation,
January 29, 2008;
117(4):
e25 - e146.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Boden-Albala, R. L. Sacco, H.-S. Lee, C. Grahame-Clarke, T. Rundek, M. V. Elkind, C. Wright, E.-G. V. Giardina, M. R. DiTullio, S. Homma, et al.
Metabolic Syndrome and Ischemic Stroke Risk: Northern Manhattan Study
Stroke,
January 1, 2008;
39(1):
30 - 35.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Preiss and N. Sattar
Metabolic syndrome, dysglycaemia and vascular disease: making sense of the evidence
Heart,
December 1, 2007;
93(12):
1493 - 1496.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wang, S. Ruotsalainen, L. Moilanen, P. Lepisto, M. Laakso, and J. Kuusisto
Metabolic Syndrome and Incident End-Stage Peripheral Vascular Disease: A 14-year follow-up study in elderly Finns
Diabetes Care,
December 1, 2007;
30(12):
3099 - 3104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. L. Air and B. M. Kissela
Diabetes, the Metabolic Syndrome, and Ischemic Stroke: Epidemiology and possible mechanisms
Diabetes Care,
December 1, 2007;
30(12):
3131 - 3140.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sierra-Johnson, A. Romero-Corral, V. K. Somers, F. Lopez-Jimenez, G. Walldius, A. Hamsten, M.-L. Hellenius, and R. M. Fisher
ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects
Eur. Heart J.,
November 1, 2007;
28(21):
2637 - 2643.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Schindler
Review: The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis?
Therapeutic Advances in Cardiovascular Disease,
October 1, 2007;
1(1):
7 - 26.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. H. Curtis, B. G. Hammill, M. A. Bethel, K. J. Anstrom, J. S. Gottdiener, and K. A. Schulman
Costs of the Metabolic Syndrome in Elderly Individuals: Findings from the Cardiovascular Health Study
Diabetes Care,
October 1, 2007;
30(10):
2553 - 2558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Park, N. Yasuda, S. Toyonaga, S. M. Yamada, H. Nakabayashi, M. Nakasato, T. Nakagomi, E. Tsubosaki, and K. Shimizu
Significant association between leukoaraiosis and metabolic syndrome in healthy subjects
Neurology,
September 4, 2007;
69(10):
974 - 978.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Zornitzki, O. Ayzenberg, G. Gandelman, S. Vered, E. Yaskil, D. Faraggi, A. Caspi, S. Goland, O. Shvez, A. Schattner, et al.
Diabetes, but not the metabolic syndrome, predicts the severity and extent of coronary artery disease in women
QJM,
September 1, 2007;
100(9):
575 - 581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Guize, F. Thomas, B. Pannier, K. Bean, B. Jego, and A. Benetos
All-Cause Mortality Associated With Specific Combinations of the Metabolic Syndrome According to Recent Definitions
Diabetes Care,
September 1, 2007;
30(9):
2381 - 2387.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M Zivkovic, J B. German, and A. J Sanyal
Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease
Am. J. Clinical Nutrition,
August 1, 2007;
86(2):
285 - 300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ninomiya, M. Kubo, Y. Doi, K. Yonemoto, Y. Tanizaki, M. Rahman, H. Arima, K. Tsuryuya, M. Iida, and Y. Kiyohara
Impact of Metabolic Syndrome on the Development of Cardiovascular Disease in a General Japanese Population: The Hisayama Study
Stroke,
July 1, 2007;
38(7):
2063 - 2069.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Arenillas, M. A. Moro, and A. Davalos
The Metabolic Syndrome and Stroke: Potential Treatment Approaches
Stroke,
July 1, 2007;
38(7):
2196 - 2203.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Inchiostro, G. P. Fadini, S. V. de Kreutzenberg, N. Citroni, and A. Avogaro
Is the Metabolic Syndrome a Cardiovascular Risk Factor Beyond Its Specific Components?
J. Am. Coll. Cardiol.,
June 26, 2007;
49(25):
2465 - 2465.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Gami and V. M. Montori
Reply
J. Am. Coll. Cardiol.,
June 26, 2007;
49(25):
2465 - 2466.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Eur. Heart J. Suppl.,
June 1, 2007;
9(suppl_C):
C3 - C74.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Persson, B. Hedblad, J. J. Nelson, and G. Berglund
Elevated Lp-PLA2 Levels Add Prognostic Information to the Metabolic Syndrome on Incidence of Cardiovascular Events Among Middle-Aged Nondiabetic Subjects
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2007;
27(6):
1411 - 1416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Iso, S. Sato, A. Kitamura, H. Imano, M. Kiyama, K. Yamagishi, R. Cui, T. Tanigawa, and T. Shimamoto
Metabolic Syndrome and the Risk of Ischemic Heart Disease and Stroke Among Japanese Men and Women
Stroke,
June 1, 2007;
38(6):
1744 - 1751.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Jeppesen, T. W. Hansen, S. Rasmussen, H. Ibsen, C. Torp-Pedersen, and S. Madsbad
Insulin Resistance, the Metabolic Syndrome, and Risk of Incident Cardiovascular Disease: A Population-Based Study
J. Am. Coll. Cardiol.,
May 29, 2007;
49(21):
2112 - 2119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-P. Empana, P. Duciemetiere, B. Balkau, and X. Jouven
Contribution of the metabolic syndrome to sudden death risk in asymptomatic men: the Paris Prospective Study I
Eur. Heart J.,
May 1, 2007;
28(9):
1149 - 1154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. C. Tong, A. P. Kong, W.-Y. So, X. Yang, C.-S. Ho, R. C. Ma, R. Ozaki, C.-C. Chow, C. W. Lam, J. C.N. Chan, et al.
The Usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III Definitions of the Metabolic Syndrome in Predicting Coronary Heart Disease in Subjects With Type 2 Diabetes
Diabetes Care,
May 1, 2007;
30(5):
1206 - 1211.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kahn
Metabolic Syndrome: Is It a Syndrome? Does It Matter?
Circulation,
April 3, 2007;
115(13):
1806 - 1811.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wang, S. Ruotsalainen, L. Moilanen, P. Lepisto, M. Laakso, and J. Kuusisto
The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns
Eur. Heart J.,
April 1, 2007;
28(7):
857 - 864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Dentali, E. Romualdi, and W. Ageno
The metabolic syndrome and the risk of thrombosis
Haematologica,
March 1, 2007;
92(3):
297 - 299.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-P. Empana, M. Zureik, J. Gariepy, D. Courbon, J. F. Dartigues, K. Ritchie, C. Tzourio, A. Alperovitch, and P. Ducimetiere
The Metabolic Syndrome and the Carotid Artery Structure in Noninstitutionalized Elderly Subjects: The Three-City Study
Stroke,
March 1, 2007;
38(3):
893 - 899.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Lloyd-Jones, K. Liu, L. A. Colangelo, L. L. Yan, L. Klein, C. M. Loria, C. E. Lewis, and P. Savage
Consistently Stable or Decreased Body Mass Index in Young Adulthood and Longitudinal Changes in Metabolic Syndrome Components: The Coronary Artery Risk Development in Young Adults Study
Circulation,
February 27, 2007;
115(8):
1004 - 1011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Rosamond, K. Flegal, G. Friday, K. Furie, A. Go, K. Greenlund, N. Haase, M. Ho, V. Howard, B. Kissela, et al.
Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Circulation,
February 6, 2007;
115(5):
e69 - e171.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Gami, B. J. Witt, D. E. Howard, P. J. Erwin, L. A. Gami, V. K. Somers, and V. M. Montori
Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death: A Systematic Review and Meta-Analysis of Longitudinal Studies
J. Am. Coll. Cardiol.,
January 30, 2007;
49(4):
403 - 414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. H. Opie
Metabolic Syndrome
Circulation,
January 23, 2007;
115(3):
e32 - e35.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Eur. Heart J.,
January 1, 2007;
28(1):
88 - 136.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Li, E. S Ford, L. C McGuire, and A. H Mokdad
Association of metabolic syndrome and insulin resistance with congestive heart failure: findings from the Third National Health and Nutrition Examination Survey
J. Epidemiol. Community Health,
January 1, 2007;
61(1):
67 - 73.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lorenzo, K. Williams, K. J. Hunt, and S. M. Haffner
The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and Diabetes
Diabetes Care,
January 1, 2007;
30(1):
8 - 13.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Mancia, M. Bombelli, G. Corrao, R. Facchetti, F. Madotto, C. Giannattasio, F. Q. Trevano, G. Grassi, A. Zanchetti, and R. Sega
Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study: Daily Life Blood Pressure, Cardiac Damage, and Prognosis
Hypertension,
January 1, 2007;
49(1):
40 - 47.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. O. Palmieri, I. Grattagliano, P. Portincasa, and G. Palasciano
Systemic Oxidative Alterations Are Associated with Visceral Adiposity and Liver Steatosis in Patients with Metabolic Syndrome
J. Nutr.,
December 1, 2006;
136(12):
3022 - 3026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Iribarren, A. S. Go, G. Husson, S. Sidney, J. M. Fair, T. Quertermous, M. A. Hlatky, and S. P. Fortmann
Metabolic Syndrome and Early-Onset Coronary Artery Disease: Is the Whole Greater Than Its Parts?
J. Am. Coll. Cardiol.,
November 7, 2006;
48(9):
1800 - 1807.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Oda
Criteria for diagnosing the metabolic syndrome.
Am. J. Clinical Nutrition,
November 1, 2006;
84(5):
1251 - 1252.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Oda
The metabolic syndrome (emperor) wears no clothes: response to kahn.
Diabetes Care,
November 1, 2006;
29(11):
2566 - 2566.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bochud, J. Nussberger, P. Bovet, M. R. Maillard, R. C. Elston, F. Paccaud, C. Shamlaye, and M. Burnier
Plasma Aldosterone Is Independently Associated With the Metabolic Syndrome
Hypertension,
August 1, 2006;
48(2):
239 - 245.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Blaha and T. A. Elasy
Clinical Use of the Metabolic Syndrome: Why the Confusion?
Clin. Diabetes,
July 1, 2006;
24(3):
125 - 131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kahn
The Metabolic Syndrome (Emperor) Wears No Clothes
Diabetes Care,
July 1, 2006;
29(7):
1693 - 1696.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Rana, A. C. Jansen, A. H. Zwinderman, M. Nieuwdorp, E. S. van Aalst-Cohen, J. W. Jukema, M. D. Trip, and J. J.P. Kastelein
Metabolic Syndrome and Risk of Coronary, Cerebral, and Peripheral Vascular Disease in a Large Dutch Population With Familial Hypercholesterolemia
Diabetes Care,
May 1, 2006;
29(5):
1125 - 1127.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Schillaci, M. Pirro, G. Pucci, M. R. Mannarino, F. Gemelli, D. Siepi, G. Vaudo, and E. Mannarino
Different Impact of the Metabolic Syndrome on Left Ventricular Structure and Function in Hypertensive Men and Women
Hypertension,
May 1, 2006;
47(5):
881 - 886.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Bernstein, J. Berry, S. Kim, B. Canavan, and S. K. Grinspoon
Effects of Etanercept in Patients With the Metabolic Syndrome.
Arch Intern Med,
April 24, 2006;
166(8):
902 - 908.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Farmer
Metabolic syndrome and mortality.
BMJ,
April 15, 2006;
332(7546):
882 - 882.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Natali, E. Toschi, S. Baldeweg, D. Ciociaro, S. Favilla, L. Sacca, and E. Ferrannini
Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes.
Diabetes,
April 1, 2006;
55(4):
1133 - 1140.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|